PTJ
ORIC icon

Paul Tudor Jones’s Oric Pharmaceuticals ORIC Stock Holding History

Paul Tudor Jones’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$459K Buy
42,409
+8,721
+26% +$79.1K ﹤0.01% 2883
2026
Q1 		$427K Buy
+33,688
New +$382K ﹤0.01% 2919
2025
Q3 		– Sell
-33,530
Closed -$340K – 3726
2025
Q2 		$340K Sell
33,530
-1,755
-5% -$11.8K ﹤0.01% 2818
2025
Q1 		$197K Buy
+35,285
New +$309K ﹤0.01% 2871
2024
Q3 		– Sell
-33,391
Closed -$236K – 3000
2024
Q2 		$236K Buy
33,391
+4,186
+14% +$37.5K ﹤0.01% 2099
2024
Q1 		$402K Buy
+29,205
New +$347K ﹤0.01% 1743

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Paul Tudor Jones's ORIC Position: Q2 2026 in Review

Paul Tudor Jones increased its Oric Pharmaceuticals (ORIC) stake by 26% in Q2 2026, buying an estimated $79.1K and bringing the position to 42,409 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #2883.

Paul Tudor Jones first reported a position in ORIC in Q1 2024 and has held it in 6 quarters since. 179 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Paul Tudor Jones held 42,409 shares of Oric Pharmaceuticals worth $459K as of Q2 2026.
  • Paul Tudor Jones bought 8,721 Oric Pharmaceuticals shares in Q2 2026, an estimated $79.1K.
  • Oric Pharmaceuticals made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2883 holding.
  • Paul Tudor Jones first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
  • 179 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.